Abstract 13709: Cardioprotective Mechanisms of FTO-Regulated m6A in Heart Failure
Originally published30 Oct 2022Circulation. 2022;146:A1370https://www.ahajournals.org/doi/abs/10.1161/circ.146.suppl_1.13709FTO inhibits oxidative stress by mediating m6A demethylation of Nrf2 to alleviate cerebral ischemia/reperfusion injury
https://link.springer.com/article/10.1007/s13105-022-00929-xCerebroprotective Role of N6-Methyladenosine Demethylase FTO (Fat Mass and Obesity-Associated Protein) After Experimental Stroke
https://link.springer.com/article/10.1007/s13105-022-00929-x
More emerging evidence that zantrene may have a role in cardioprotection but also for the brain post CVA!!
General Comments / Chat, page-6053
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.69 |
Change
-0.090(5.06%) |
Mkt cap ! $288.0M | |||
| Open | High | Low | Value | Volume |
| $1.78 | $1.78 | $1.63 | $449.0K | 263.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2300 | $1.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.69 | 8176 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |